1. Home
  2. TYRA vs WKC Comparison

TYRA vs WKC Comparison

Compare TYRA & WKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$30.11

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo World Kinect Corporation

WKC

World Kinect Corporation

HOLD

Current Price

$26.07

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
WKC
Founded
2018
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil Refining/Marketing
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TYRA
WKC
Price
$30.11
$26.07
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$34.80
$28.75
AVG Volume (30 Days)
581.6K
922.2K
Earning Date
11-05-2025
02-19-2026
Dividend Yield
N/A
3.03%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$37,648,100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.42
$22.71
52 Week High
$31.56
$31.54

Technical Indicators

Market Signals
Indicator
TYRA
WKC
Relative Strength Index (RSI) 66.88 52.45
Support Level $27.40 $25.84
Resistance Level $31.56 $28.16
Average True Range (ATR) 2.01 0.82
MACD -0.11 -0.10
Stochastic Oscillator 71.65 28.67

Price Performance

Historical Comparison
TYRA
WKC

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About WKC World Kinect Corporation

World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.

Share on Social Networks: